Detalhe da pesquisa
1.
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.
Prostate
; 84(1): 100-110, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796107
2.
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.
Cancer Res Commun
; 3(11): 2358-2374, 2023 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823778
3.
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches.
Endocr Relat Cancer
; 28(8): T51-T66, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792558
4.
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature.
PLoS One
; 16(1): e0245602, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471819
5.
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer.
Clin Cancer Res
; 27(3): 759-774, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33199493
6.
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer.
Cancer Res
; 81(18): 4736-4750, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312180
7.
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.
Clin Cancer Res
; 27(17): 4923-4936, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145028
8.
Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity.
J Pharmacol Exp Ther
; 335(2): 273-83, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20716622
9.
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts.
Eur Urol
; 77(2): 144-155, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227306
10.
Expression of human inducible nitric oxide synthase in response to cytokines is regulated by hypoxia-inducible factor-1.
Free Radic Biol Med
; 130: 278-287, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30391674
11.
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.
J Clin Invest
; 129(10): 4492-4505, 2019 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31361600
12.
The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.
Oncotarget
; 7(17): 24284-302, 2016 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27015368
13.
p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell lines.
Chem Biol Interact
; 230: 40-9, 2015 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682698
14.
Epigenetic characterization of the growth hormone gene identifies SmcHD1 as a regulator of autosomal gene clusters.
PLoS One
; 9(5): e97535, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24818964
15.
A TRIP230-retinoblastoma protein complex regulates hypoxia-inducible factor-1α-mediated transcription and cancer cell invasion.
PLoS One
; 9(6): e99214, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24919196
16.
Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines.
PLoS One
; 7(1): e29545, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22235307